Phase III Trial of UBT251 in Moderate-to-Severe OSA With Obesity: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study.

Clinical trial NCT07767942 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07767942
Sponsor: The United Bio-Technology (Hengqin) Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Obstructive Sleep Apnea, Obesity

Start date: 2026-09-18
Primary completion: 2028-09-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.